| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $86.2M | -94.7% |
| Cost of Revenue | $2.8M | -98.1% |
| R&D Expense | $589.7M | +24.2% |
| SG&A Expense | $178.0M | +10.1% |
| Operating Income | -$684.3M | -182.1% |
| Pre-tax Income | -$628.2M | -183.3% |
| Income Tax | -$13.1M | -105.5% |
| Net Income | -$615.1M | -219.2% |
| EPS (Basic) | -$4.59 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $241.6M | -71.5% |
| Short-term Investments | $1.27B | -16.5% |
| Current Assets | $1.59B | -37.0% |
| Total Assets | $1.92B | -31.5% |
| Current Liabilities | $175.4M | -65.7% |
| Total Liabilities | $328.8M | -54.6% |
| Stockholders' Equity | $1.59B | -23.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$778.8M | -146.8% |
| Capital Expenditures | $21.6M | -68.3% |
| Investing Cash Flow | $164.6M | +113.8% |
| Financing Cash Flow | $7.5M | -78.5% |
| Free Cash Flow | -$800.4M | -150.2% |
| -218.0% |
| EPS (Diluted) | -$4.59 | -219.8% |